###begin article-title 0
Proton Pump Inhibitors Exert Anti-Allergic Effects by Reducing TCTP Secretion
###end article-title 0
###begin p 1
Conceived and designed the experiments: ESH KL. Performed the experiments: SC HJM MK. Analyzed the data: SC ESH KL. Wrote the paper: SC KL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
Extracellular translationally controlled tumor protein (TCTP) is known to play a role in human allergic responses. TCTP has been identified outside of macrophages, in activated mononuclear cells, and in biological fluids from allergic patients. Even TCTP devoid of signal sequences, is secreted to extracellular environment by an yet undefined mechanism. This study is aimed at understanding the mechanism of TCTP release and its regulation. A secondary goal is to see if inhibitors of TCTP release can serve as potential anti-allergic asthmatic drugs.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 298 299 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 345 353 345 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 649 650 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 652 653 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 411 417 <span type="species:ncbi:10090">murine</span>
###xml 667 673 <span type="species:ncbi:10090">murine</span>
Using Western blotting assay in HEK293 and U937 cells, we found that TCTP secretion is reduced by omeprazole and pantoprazole, both of which are proton pump inhibitors. We then transfected HEK293 cells with proton pump expression vectors to search for the effects of exogeneously overexpressed H+/K+-ATPase on the TCTP secretion. Based on these in vitro data we checked the in vivo effects of pantoprazole in a murine model of ovalbumin-induced allergy. Omeprazole and pantoprazole reduced TCTP secretion from HEK293 and U937 cells in a concentration-dependent fashion and the secretion of TCTP from HEK293 cells increased when they over-expressed H+/K+-ATPase. In a murine model of ovalbumin-induced allergy, pretreatment with pantoprazole reduced infiltration of inflammatory cells, increased goblet cells, and increased TCTP secretion induced by OVA challenge.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Since Omeprazole and pantoprazole decrease the secretion of TCTP which is associated with the development of allergic reaction, they may have the potential to serve as anti-allergic (asthmatic) drugs.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Bommer1">[1]</xref>
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Teshima1">[3]</xref>
###xml 353 356 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-MacDonald1">[4]</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Liu1">[5]</xref>
###xml 517 520 517 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Warner1">[9]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Schroeder1">[10]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-BheekhaEscura1">[11]</xref>
###xml 317 322 <span type="species:ncbi:9606">human</span>
###xml 522 527 <span type="species:ncbi:9606">Human</span>
Translationally controlled tumor protein (TCTP) is expressed in almost all mammalian tissues. Intracellular TCTP levels respond to various extracellular signals and agents such as growth factors, cytokines, and stress conditions [1]-[3]. Extracellular TCTP has also been reported to be present in the supernatants of human U937 macrophage cell cultures [4], outside of mononuclear cells and platelets, in nasal washings, skin blister fluids, and bronchoalveolar lavage (BAL) fluids during late allergic reactions [5]-[9]. Human recombinant TCTP stimulates the secretion of histamine, IL-4 and IL-13 from basophils. TCTP also causes chemotaxis and IL-8 secretion from eosinophils [10], [11].
###end p 9
###begin p 10
###xml 538 542 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Muesch1">[12]</xref>
###xml 544 548 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Kuchler1">[13]</xref>
###xml 1079 1083 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Nickel1">[14]</xref>
###xml 285 288 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Most secretory proteins have signal sequences composed of 13-30 hydrophobic amino acids at their N-termini. Some leaderless proteins, however, can exit from a cell in an ER-Golgi independent fashion, for example, interleukins 1alpha and 1beta, FGF2, thioredoxin, lipocortin, galectin, HIV-tat protein, annexin, and vas deferens protein. TCTP, with no classical leader sequence that might explain its extracellular presence, belongs to these unusual proteins, which exit from a cell without passing through the classical secretion pathway [12], [13]. How these proteins are non-classically secreted from cell has not yet been defined. Contrary to an early perception, the selective release of the 'leaderless' proteins can be unequivocally distinguished from conventional ER-Golgi-mediated protein secretion which is not a consequence of impaired plasma membrane integrity or cell death. Several potential mechanisms were proposed for such unconventional protein secretion, involving: lysosomal and exosomal secretion, plasma membrane resident transporters, and membrane blebbing [14], but a definitive understanding of the secretion mechanism for leaderless proteins has not emerged.
###end p 10
###begin p 11
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Im1">[15]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Lorentzon1">[16]</xref>
###xml 460 461 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Bell1">[17]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Wandall1">[18]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Suzuki1">[19]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Yoshida1">[20]</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Agastya1">[21]</xref>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-ZedtwitzLiebenstein1">[22]</xref>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
Omeprazole is an active ingredient of Prilosec, used to treat peptic ulcer. It is a specific inhibitor of the human gastric H+/K+-ATPase [15], which at neutral pH, permeates cell membranes and accumulates in acidic cellular compartments, such as lysosomes, where it undergoes protonation. The protonated form becomes an active sulfenamide compound and acts as a potent proton pump inhibitor (PPI) [16]. Activated omeprazole was shown to inhibit human gastric H+/K+-ATPase and halt acid secretion by parietal cells [17]. Pantoprazole is a modified form of omeprazole and also is also a PPI. PPIs have also been shown to inhibit neutrophil functions [18] including adhesion to endothelial cells [19], [20], phagocytosis, acidification of phagolysosomes [21], and production of reactive oxygen intermediates [22].
###end p 11
###begin p 12
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 280 282 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 349 350 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Florkiewicz1">[23]</xref>
###xml 475 483 475 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 514 521 514 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Although the secretion of TCTP is well documented, how it is regulated is not clear. Because the factors contributing to its secretion and the underlying mechanisms are still unclear we tried various ATPase inhibitors (Na+/K+-ATPase, plasmamembrane H+/K+-ATPase, plasmamembrane Ca2+-ATPase) based on the report that FGF-2 release is related to Na+/K+-ATPase inhibitors [23]. We found that omeprazole and pantoprazole inhibit TCTP release in a concentration-dependent fashion in vitro. We confirmed this phenomenon in vivo and came to the conclusion that omeprazole and pantoprazole have the anti-allergic asthmatic potential by reducing TCTP secretion.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Antibodies
###end title 14
###begin p 15
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 50 56 <span type="species:ncbi:9986">rabbit</span>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Mouse 12CA5 anti-HA monoclonal antibody, purified rabbit anti-GFP polyclonal antibody, mouse anti-Na+/K+-ATPase alpha1 monoclonal antibody (C464.6), and anti-flag(R) M2 monoclonal antibody were purchased from Zymed Laboratories Inc., InVitrogen, Upstate, and Sigma, respectively.
###end p 15
###begin title 16
Cell culture and cell secretion assays
###end title 16
###begin p 17
###xml 111 117 <span type="species:ncbi:9913">bovine</span>
###xml 271 277 <span type="species:ncbi:9913">bovine</span>
HEK293 cells (ATCC) were cultured in Dulbecco's modified Eagle's media (DMEM; Invitrogen) containing 10% fetal bovine serum, 1% penicillin-streptomycin, 2 mM glutamine, and 20 mM HEPES. U937 cells (ATCC) were cultured in RPMI-1640 media (Invitrogen) containing 10% fetal bovine serum, 1% penicillin-streptomycin, and 10 mM HEPES. On the day of experiment, HEK293 cells were detached from culture dishes, using with trypsin-EDTA, and washed twice with serum-free media. U937 cells were collected by centrifugation and washed twice with serum-free media. The collected cells were stained with trypan blue, counted for live cells, and plated. The cells were resuspended in serum-free media and incubated for indicated times with or without omeprazole (Sigma) and pantoprazole (Byk Gulden, Germany) or ionomycin (Sigma). Cell viability was assessed by trypan blue exclusion or CCK-8 (Dojindo Molecular Technologies, Japan). At the end of incubation, supernatants were collected and centrifuged (300xg) for 5 min to remove non-adherent cells. The supernatants were recentrifuged (5,000xg) for 10 min to remove cell debris and nuclei and concentrated by centrifugation using vivaspin 500 (10,000 molecular weight cut-off; Sartorius, France), and resuspended in 4x SDS sample buffer. Each sample (indicated amount of total proteins was resolved by SDS-PAGE. Cells were solubilized in lysis buffer containing 1% Nonidet P-40, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.25% deoxycholate, 2 mM sodium orthovanadate, 1 mM sodium fluoride and mixture of protease inhibitors. After transfer the membranes were routinely blotted.
###end p 17
###begin title 18
Plasmid construction
###end title 18
###begin p 19
###xml 120 123 120 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 212 215 212 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 341 342 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 372 373 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 375 376 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 447 451 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 459 462 451 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 524 528 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 536 539 528 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 636 637 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 639 640 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 705 709 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Yoon1">[24]</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 45 48 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 166 169 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 333 336 <span type="species:ncbi:10116">rat</span>
###xml 367 370 <span type="species:ncbi:10116">rat</span>
###xml 630 633 <span type="species:ncbi:10116">Rat</span>
To construct the plasmid, human TCTP/p3XFLAG-CMV-14, human TCTP insert was made by PCR amplification using primers with BamHI and EcoRI sites. Insert DNA and p3XFLAG-CMV-14 empty vector were excised by BamHI and EcoRI restriction enzymes and sticky-end ligated. The plasmid was confirmed by DNA sequencing. To construct the plasmid, rat H+/K+-ATPase alpha1/pEGFP-N1, rat H+/K+-ATPase alpha1 insert was made by PCR amplification using primers with HindIII and XhoI sites. Insert DNA and pEGFP-N1 empty vector were excised by HindIII and XhoI restriction enzymes and sticky-end ligated. The plasmid was confirmed by DNA sequencing. Rat Na+/K+-ATPase beta1/pcDNAI-neo was constructed as previously described [24].
###end p 19
###begin title 20
Transfections
###end title 20
###begin p 21
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 180 181 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 210 211 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 213 214 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 172 175 <span type="species:ncbi:10116">rat</span>
###xml 204 207 <span type="species:ncbi:10116">rat</span>
###xml 229 234 <span type="species:ncbi:9606">human</span>
HEK293 cells were plated and a day later, transfected by the Ca2PO4 precipitation method or WelFect EX PLUS reagent (WelGene, Korea). In triple transfections, the ratio of rat H+/K+-ATPase alpha1-GFP: HA-rat Na+/K+-ATPase beta1: human TCTP-3X flag was 3:1:1. Secretion assays were performed after 2 days. In some experiments, omeprazole or pantoprazole was added during the secretion assay.
###end p 21
###begin title 22
Development of airway inflammation
###end title 22
###begin p 23
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
Male BALB/c mice were purchased from the Central Lab. Animal Inc. (Korea), and were kept in our animal facility for at least 1 week before use. All animals were handled in strict accordance with good animal practice as defined by the relevant national and/or local animal welfare bodies, and all animal work was approved by Ewha Womans University's institutional animal care and use committee. The mice were sensitized on day 0, and on day 14, with intraperitoneal (i.p.) injection of OVA (Sigma, 50 microg per each) in alum (Thermo scientific). Starting on day 28, the sensitized mice were challenged with daily intranasal injections (with pipetman) of PBS or OVA (300 microg per each) for seven days. For pantoprazole treatment, the mice were pre-treated (i.p.) with indicated dose of Pantoloc containing pantoprazole as active ingredient; (Byk Gulden, Germany) 30 min prior to OVA challenge and sacrificed on day 37. Bronchoalveolar lavage lung fluids (BALF) and lungs were collected. Western blotting for TCTP detection was performed on BALF.
###end p 23
###begin title 24
Lung analyses
###end title 24
###begin p 25
Lung tissues were fixed in 4% paraformaldehyde, dehydrated in alcohol, embedded in paraffin and cut into 5 microm thick slices. Tissue section was stained with PAS solution (Sigma). Images were acquired using optical microscope (Nikon Eclipse E200, Japan).
###end p 25
###begin title 26
Statistics
###end title 26
###begin p 27
Data are expressed as mean+/-S.D. Significances of differences between two groups were determined using the unpaired student's t-test. Statistical significance was set at p<0.05.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Omeprazole and pantoprazole inhibit TCTP secretion from U937 and HEK293 cells
###end title 29
###begin p 30
###xml 156 159 156 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-MacDonald1">[4]</xref>
###xml 512 521 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g001">Figure 1A</xref>
###xml 856 865 853 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g001">Figure 1A</xref>
###xml 1531 1540 1528 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g002">Figure 2A</xref>
We first established the incubation period needed for detection of secreted TCTP. Extracellular TCTP was first identified in the supernatants of U937 cells [4] and further studies on TCTP release were done using HEK293 cells. U937 cells were incubated in serum-free RPMI media for 0, 1, 2, 3, 4, or 5 h, and the collected supernatants and cells were processed, resolved by SDS-PAGE, and immunoblotted for TCTP. The secreted amount of TCTP increased with incubation time and reached maximum after 5 h incubation (Figure 1A). To ensure that TCTP resulted from an active secretion process rather than from contamination from cell lysis or non-specific release, the supernatants were also immunoblotted against beta-tubulin, one of the abundant cytosolic proteins. Beta tubulin was clearly identified in cell lysates but not in the corresponding supernatants (Figure 1A). In HEK293 cells, it was difficult to detect the secretion of endogeneous TCTP. HEK293 cells were therefore transfected with TCTP-3Xflag and 2 days later placed in serum-free media and their supernatants were assayed for the presence of TCTP. Transfected HEK293 cells were incubated in serum-free DMEM media for 0, 0.5, 1, or 3 h, and the collected supernatants and cells were processed, and resolved by SDS-PAGE, and immunoblotted for TCTP-3Xflag. By 1 h, exogenously expressed TCTP was detected in HEK293 cell-derived supernatants; these levels were not further enhanced at 3 h. As with U937, there was no evidence of cell lysis or non-specific protein release (Figure 2A).
###end p 30
###begin title 31
TCTP secretion, both constitutive and induced from U-937 cells is inhibited by omeprazole and pantoprazole.
###end title 31
###begin p 32
###xml 198 204 <span type="species:ncbi:9986">rabbit</span>
###xml 277 283 <span type="species:ncbi:9986">rabbit</span>
(A) TCTP secretion is increased with incubation time in serum-free conditioned media. beta-tubulin is a loading control in cells, while it is a cell lysis marker in media. WB: anti-beta-tubulin Ab (rabbit polyclonal antibody, H-235, Santa Cruz Biotechnology) and anti-TCTP Ab (rabbit polyclonal antiserum, generated using recombinant His-tagged TCTP as the immunogen), (B) Omeprazole treatment during incubation in conditioned media (5 h) is capable of decreasing of TCTP secretion in concentration-dependent manner. 'O' in the graph means omeprazole. WB: anti-TCTP Ab, (C) Pantoprazole treatment (5 h) inhibits TCTP secretion in concentration-dependent manner. 'P' in the graph means pantoprazole. WB: anti-TCTP Ab, (D) Both of omeprazole (O) and pantoprazole (P) pre-treatments reduce the TCTP secretion induced by ionomycin (IM) treatment (2 microM, 10 min). 1 microM omeprazole and 100 microM pantoprazole were used. Both chemicals were treated 1 h prior to ionomycin treatment. WB: anti-TCTP Ab. Data from panel B to panel D represent means+/-S.D. from three independent experiments. #: inhibition, p<0.05, vs. non-treated cells (panel B, C), vs. IM-treated cells (panel D), ##: inhibition, p<0.01, vs. non-treated cells (panel B, C), vs. IM-treated cells (panel D), **: increase, p<0.01, vs. non-treated cells.
###end p 32
###begin title 33
The secretion of exogeneously expressed TCTP in HEK293 cells is inhibited by omeprazole and pantoprazole.
###end title 33
###begin p 34
(A) TCTP secretion is increased with incubation time in serum-free conditioned media. beta-tubulin is a loading control in cells, while it is a cell lysis marker in media. WB: anti-beta-tubulin Ab and anti-flag Ab, (B) Omeprazole treatment during incubation in conditioned media (3 h) is capable of decreasing of TCTP secretion in concentration-dependent manner. 'O' in the graph means omeprazole. WB: anti-flag Ab, (C) Pantoprazole treatment (3 h) inhibits TCTP secretion in concentration-dependent manner. 'P' in the graph means pantoprazole. WB: anti-flag Ab, (D) Both of omeprazole (O) and pantoprazole (P) pre-treatments reduce the TCTP secretion induced ionomycin (IM) treatment (2 microM, 10 min). 1 microM omeprazole and 100 microM pantoprazole were used. Both chemicals were treated 1 h prior to ionomycin treatment. WB: anti-flag Ab. Data from panel B to panel D represent means+/-S.D. from three independent experiments. #: inhibition, p<0.05, vs. non-treated cells (panel B, C), vs. IM-treated cells (panel D), ##: inhibition, p<0.01, vs. non-treated cells (panel B, C), vs. IM-treated cells (panel D), **: increase, p<0.01, vs. non-treated cells.
###end p 34
###begin p 35
###xml 287 296 283 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g001">Figure 1B</xref>
###xml 339 348 331 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g001">Figure 1C</xref>
###xml 463 476 455 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g002">Figure 2B, 2C</xref>
###xml 717 718 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 720 721 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1288 1290 1276 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1526 1535 1514 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g001">Figure 1D</xref>
###xml 1610 1619 1598 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g002">Figure 2D</xref>
When the secretion assays were performed with serum-free media supplemented with omeprazole or pantoprazole, the amounts of TCTP detected in the conditioned media were reduced in a concentration dependent fashion. In U937 cells, 10 microM omeprazole reduced TCTP secretion by about 60% (Figure 1B) and by 50% with 100 microM pantoprazole (Figure 1C). In HEK293 cells, the reduction of TCTP secretion was 60% and 40% for omeprazole and pantoprazole, respectively (Figure 2B, 2C). In these experiments, we used omeprazole at lower concentration than pantoprazole for the following reasons. First, omeprazole showed cytotoxic effect at concentrations higher than 100 microM, probably due to the excessive inhibition of H+/K+-ATPase. Second, the reconstituted pantoprazole caused precipitation after freezing and thawing and precipitation causes some reduction in activity. To avoid such precipitations, it was dissolved as soon as it was reconstituted, and divided into small aliquots. The viability of the cells treated by omeprazole and pantoprazole was confirmed with trypan blue or CCK-8 kit; there was no significant difference between untreated and treated cells. The inhibition of TCTP secretion by omeprazole and pantoprazole was also seen in ionomycin (IM) treated cells. IM is a Ca2+ ionophore and induces secretion of many proteins in an ER-Golgi independent process. With U937 cells, IM treatment increased TCTP secretion by approximately 50% and pre-treatment with omeprazole and pantoprazole blocked this increase (Figure 1D). HEK293 cells transfected with TCTP-3Xflag also showed similar patterns (Figure 2D).
###end p 35
###begin p 36
These results indicate that omeprazole and pantoprazole inhibit TCTP secretion, regardless of whether it is endogeneously or exogeneously expressed. Also secretion inducers had no effects on these phenomena.
###end p 36
###begin title 37
###xml 18 19 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 21 22 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
alpha-subunit of H+/K+-ATPase modulates TCTP export
###end title 37
###begin p 38
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 241 242 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 244 245 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 376 377 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 379 380 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 416 417 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 419 420 404 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 450 426 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g003">Figure 3B</xref>
###xml 902 911 859 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g003">Figure 3C</xref>
###xml 1039 1047 996 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g002">Figure 2</xref>
###xml 353 356 <span type="species:ncbi:10116">rat</span>
###xml 393 396 <span type="species:ncbi:10116">rat</span>
The major effect of PPIs is to inhibit the ion transport activity of H+/K+-ATPase by binding to the catalytic alpha-subunit. Since omeprazole and pantoprazole inhibited TCTP export, we investigated whether changes in alpha-subunit level of H+/K+-ATPase affect TCTP export. HEK293 cells were co-transfected with plasmid expression vectors encoding TCTP, rat alpha1-subunit of H+/K+-ATPase, and rat beta1-subunit of Na+/K+-ATPase. As shown in Figure 3B, co-overexpression of alpha1 and beta1 with TCTP elevated TCTP secretion by over 60%, compared with control cells expressing TCTP only. This increase was not seen in the cells transfected with beta1 and TCTP except alpha1. This suggests that the complex of alpha1-subunit and beta1-subunit is in some way involved in TCTP export. TCTP secretion induced by co-expression of alpha1 and beta1 was reduced by pre-treatment of omeprazole and pantoprazole (Figure 3C). But only pantoprazole had a statistically significant effect. Since the concentration of omeprazole and pantoprazole used in Figure 2 was not sufficient to reverse the increase of TCTP release, a tenfold concentration was used. Cell viability was not changed by these pre-treatments.
###end p 38
###begin title 39
Increased TCTP secretion by over-expression of proton pump is inhibited by pantoprazole in HEK293.
###end title 39
###begin p 40
###xml 224 225 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 227 228 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 257 258 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 260 261 242 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 502 503 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 505 506 484 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 527 528 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 530 531 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 691 692 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 694 695 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 713 714 681 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 716 717 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 219 222 <span type="species:ncbi:10116">rat</span>
###xml 251 254 <span type="species:ncbi:10116">rat</span>
###xml 330 336 <span type="species:ncbi:9986">rabbit</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
(A) Comparison of protein expressions in control and Halphabeta samples. Control sample was transfected with two empty vectors (pEGFP-N1 and pcDNAI-neo) and TCTP-3Xflag construct. Halphabeta sample was transfected with rat H+/K+-ATPase alpha1-GFP, HA-rat Na+/K+-ATPase beta1, and TCTP-3Xflag constructs. WB: anti-GFP Ab (purified rabbit polyclonal antibody, InVitrogen), anti-HA Ab (mouse 12CA5 monoclonal antibody, Santa Cruz), and anti-flag Ab, (B) TCTP secretion is increased by over-expression of H+/K+-ATPase alpha1 and Na+/K+-ATPase beta1. Both groups of cells were incubated for 3 h in conditioned media. WB: anti-flag Ab, (C) The secretion assay data for the cells transfected with H+/K+-ATPase alpha1, Na+/K+-ATPase beta1, and TCTP. Pantoprazole (1 mM) or omeprazole (1 mM) was treated during 3 h secretion assay. 'O' in the graph means omeprazole and 'P' does pantoprazole. WB: anti-flag Ab. Data of panel B and panel C represent means+/-S.D. from three independent experiments. #: inhibition, p<0.05, vs. non-treated cells, *: increase, p<0.05, vs. the cells transfected with two empty vectors (pEGFP-N1 and pcDNAI-neo) and TCTP-3Xflag construct.
###end p 40
###begin title 41
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Effect of pantoprazole on the TCTP levels in BAL fluids from OVA-sensitized mice
###end title 41
###begin p 42
###xml 91 94 91 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Liu1">[5]</xref>
###xml 95 98 95 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Warner1">[9]</xref>
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 400 409 400 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g004">Figure 4A</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 783 789 <span type="species:ncbi:10090">murine</span>
It has been shown that TCTP appears in biological fluids during the late allergic reaction [5]-[9]. We used the OVA-challenged mice for examining the effect of pantoprazole in vivo. Periodic Acid-Schiff (PAS) staining of lung sections showed a marked increase in mucus-producing granular goblet cells in the proximal airways of OVA-sensitized/challenged mice relative to saline-treated control mice (Figure 4A). The increase of PAS positive goblet cells in mice were reduced by pretreatment with pantoprazole in a dose dependent manner. Pantoprazole pre-treatment also reduced markedly, the infiltration of the airway wall by PAS positive inflammatory cells. Increase of mucus-producing goblet cells and inflammatory cell infiltration is a prominent histopathological feature of the murine asthmatic lung.
###end p 42
###begin title 43
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Pantoprazole alleviates asthmatic responses and inhibits TCTP secretion in OVA-sensitized/challenged mice.
###end title 43
###begin p 44
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
###xml 523 527 <span type="species:ncbi:10090">Mice</span>
(A) PAS staining results of lung sections. OVA-sensitized/challenged mice show marked increase of the mucus-producing granular goblet cells in the bronchial alveoli relative to sham mice. The increased PAS positive goblet cells in OVA challenged mice were reduced by pantoprazole pre-treatment in amount dependent manner. Pantoprazole pre-treatment also reduced marked infiltration of the airway wall by PAS positive inflammatory cells, (B) Western blotting data using BALF of allergic mouse model. WB: anti-TCTP antibody. Mice were sensitized with OVA and challenged with PBS or OVA five times every other day. 'P' means pantoprazole and indicated numbers (10 and 100) mean dosage. #: inhibition, p<0.05, vs. OVA challenged but no pre-treatment, ##: inhibition, p<0.01, vs. OVA challenged but no pre-treatment, **: increase, p<0.01, vs. sham group. sham: negative control, OVA sensitized but not challenged, n = 4. OVA: positive control, OVA sensitized and challenged with no pre-treatment, n = 5. P 10: OVA sensitized and challenged with pantoprazole 10 mg/kg pre-treatment (30 min), n = 6. P 100: OVA sensitized and challenged with pantoprazole 100 mg/kg pre-treatment (30 min), n = 6.
###end p 44
###begin p 45
###xml 77 86 77 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g004">Figure 4B</xref>
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Next, we examined the changes in TCTP secretion into BAL fluids. As shown in Figure 4B, OVA challenged mice showed increased TCTP in BAL fluids. Similar to in vitro data, pantoprazole pre-treatment inhibited TCTP secretion to that present in sham group. These results indicate that pantoprazole might exert its anti-allergic effect by blocking TCTP secretion.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 705 706 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 708 709 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1405 1413 1405 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g001">Figs. 1B</xref>
###xml 1415 1417 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005732-g002">2B</xref>
TCTP is known to be a secreted protein, but the factors contributing to its secretion and the underlying mechanisms are still unclear. There are many studies about the secretion mechanisms of the other non-typically secreted proteinsother than TCTP. Secretion of the catalytic subunit of Na+/K+-ATPase is reported to be related to fibroblast growth factor-2 (FGF-2). In this study, the authors searched for some small molecules that might cause specific perturbation of the plasma membrane and interfere with FGF-2 release. They assumed that there is a plasma membrane translocation apparatus (PMTA) through which FGF-2 is exported. They found cardenolides like ouabain inhibit FGF-2 secretion and that Na+/K+-ATPase acts as a PMTA component or regulator. Based on this report, we searched for the inhibitors that act on plasma membrane and inhibit TCTP secretion. Eventually we found that proton pump inhibitors (PPIs) such as omeprazole and pantoprazole decrease the leaderless TCTP export. Possible cytotoxic effects of omeprazole and pantoprazole could be ruled out, since the trypan blue or CCK-8 assay showed no toxic effects when these drugs were used. Also, reduction in TCTP secretion by PPIs did not result from altered protein synthesis or increased instability of intracellular pools, because the treatment with these drugs did not modify the amounts of the intracellular proteins remarkably (Figs. 1B, 2B).
###end p 47
###begin p 48
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 299 300 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 302 303 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 356 357 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 363 364 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 510 511 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 513 514 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 650 654 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Jiang1">[25]</xref>
###xml 685 689 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Naseri1">[26]</xref>
###xml 731 735 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-MartinsdeOliveira1">[27]</xref>
###xml 809 810 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 812 813 808 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 911 912 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 914 915 910 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 980 981 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 983 984 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 670 675 <span type="species:ncbi:9606">human</span>
Omeprazole is used to treat peptic ulcer because it is a specific inhibitor of the human gastric H+/K+-ATPase. It is a proton pump inhibitor (PPI). Other Chemicals containing pantoprazole, rabeprazole, lansoprazole, and esomeprazole are also PPIs. PPIs interact with the catalytic alpha-subunit of H+/K+-ATPase and thereby inhibit its ability to exchange K+ for H+, hydrolyze ATP, and maintain an electrochemical gradient across the plasma membrane. In addition to reduction of gastric acid secretion through H+/K+-ATPase inhibition, various biological effects of omeprazole have been investigated, including antileishmanial (antimicrobial) activity [25], relaxation of human arteries [26], and inhibition of neutrophil chemotaxis [27]. Although the major target of PPIs is heretofore believed to be gastric H+/K+-ATPase (known to be mainly in parietal cells of stomach), other molecules, for example putative H+/K+-ATPase that are sensitive to PPIs and are unrelated to gastric H+/K+-ATPase or completely new targets other than proton pump, might be influenced by PPIs, considering the effects of PPIs on neutrophils or arteries. The data presented here suggest that the new activities of PPIs should be evaluated in the light of their role as inhibitors of TCTP and in the export of unidentified proteins export via ER-Golgi independent secretion pathways.
###end p 48
###begin p 49
###xml 138 139 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 141 142 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 325 326 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 328 329 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 404 405 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 408 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 564 565 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 567 568 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 699 700 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 702 703 694 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 787 788 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 790 791 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 944 945 924 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 947 948 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1046 1047 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1049 1050 1025 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1084 1085 1060 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1087 1088 1063 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1314 1318 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Holm1">[28]</xref>
###xml 1320 1324 1296 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Grant1">[29]</xref>
###xml 1387 1391 1363 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005732-Amzallag1">[30]</xref>
Several possible models can link, at the molecular level, the known actions of PPIs, their effect on their target (the alpha1-subunit of H+/K+-ATPase) and their ability to inhibit TCTP export. For example, the translocation apparatus exporting TCTP from cells may be regulated via the electrochemical gradient maintained by H+/K+-ATPase. If this model is correct, one needs to examine the expression of H+/K+-ATPase in U937 and HEK293 cells. Western blotting analysis using the cell lysates of U937 and HEK293 cells, showed several bands detected by anti-gastric H+/K+-ATPase alpha antibody (data not shown). But the detected proteins were smaller than expected. This indicates either that gastric H+/K+-ATPase alpha does not exist in these cells or that new, modified forms of gastric H+/K+-ATPase alpha might exist. It is also possible that there is a novel PPIs-sensitive protein target that is distinct from the catalytic alpha-subunit of H+/K+-ATPase, even though thus far, the main binding target of PPIs is the catalytic alpha-subunit of H+/K+-ATPase. Next possibility is the H+/K+-ATPase blockade may modify ongoing intracellular events, such as calcium influx and calcium mobilization, and modulate TCTP release. In previous studies, it was reported that PPIs could affect the intracellular calcium level [28], [29] and tat exocytosis is one of the mechanisms of TCTP secretion [30]. The changes in intracellular calcium levels caused by PPIs might influence exocytosis and subsequently TCTP secretion.
###end p 49
###begin p 50
###xml 647 655 647 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 660 667 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
TCTP has been implicated in various cellular processes, such as cell growth, cell cycle progression, malignant transformation, protection of cells against stress and apoptosis. In addition, an extracellular, cytokine-like functions have been established for TCTP. Thus far, there have been no reports showing that changes in intracellular TCTP levels influence the severity of allergic responses or regulation of various allergic cytokines. For TCTP to act as a regulator of allergic responses, it should be released from cells. TCTP cannot affect downstream effector cells until it is secreted. Because of their ability to inhibit TCTP secretion in vitro and in vivo, omeprazole and pantoprazole might be potentially useful as anti-allergic asthmatic therapies.
###end p 50
###begin title 51
References
###end title 51
###begin article-title 52
The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR.
###end article-title 52
###begin article-title 53
Identification of a basophil leukocyte interleukin-3-regulated protein that is identical to IgE-dependent histamine-releasing factor.
###end article-title 53
###begin article-title 54
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
Macrophage colony-stimulating factor stimulates synthesis and secretion of a mouse homolog of a human IgE-dependent histamine-releasing factor by macrophages in vitro and in vivo.
###end article-title 54
###begin article-title 55
Molecular identification of an IgE-dependent histamine-releasing factor.
###end article-title 55
###begin article-title 56
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.
###end article-title 56
###begin article-title 57
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE.
###end article-title 57
###begin article-title 58
###xml 77 82 <span type="species:ncbi:9606">human</span>
Variability of IgE-dependent histamine-releasing activity in supernatants of human mononuclear cells.
###end article-title 58
###begin article-title 59
Histamine-releasing factors and IgE heterogeneity.
###end article-title 59
###begin article-title 60
Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions.
###end article-title 60
###begin article-title 61
###xml 90 95 <span type="species:ncbi:9606">human</span>
Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils.
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10.
###end article-title 62
###begin article-title 63
A novel pathway for secretory proteins?
###end article-title 63
###begin article-title 64
Secretion of peptides and proteins lacking hydrophobic signal sequences: the role of adenosine triphosphate-driven membrane translocators.
###end article-title 64
###begin article-title 65
Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells.
###end article-title 65
###begin article-title 66
Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
###end article-title 66
###begin article-title 67
Inhibition of (H++K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.
###end article-title 67
###begin article-title 68
Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.
###end article-title 68
###begin article-title 69
Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245.
###end article-title 69
###begin article-title 70
###xml 94 113 <span type="species:ncbi:210">Helicobacter pylori</span>
Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extracts of Helicobacter pylori.
###end article-title 70
###begin article-title 71
A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions.
###end article-title 71
###begin article-title 72
###xml 79 84 <span type="species:ncbi:9606">human</span>
Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro.
###end article-title 72
###begin article-title 73
Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity.
###end article-title 73
###begin article-title 74
The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase.
###end article-title 74
###begin article-title 75
Studies on the membrane topology of the (Na,K)-ATPase.
###end article-title 75
###begin article-title 76
Antileishmanial activity of the antiulcer agent omeprazole.
###end article-title 76
###begin article-title 77
###xml 81 86 <span type="species:ncbi:9606">human</span>
Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.
###end article-title 77
###begin article-title 78
###xml 53 58 <span type="species:ncbi:9606">human</span>
The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore.
###end article-title 78
###begin article-title 79
Mechanical manipulation of polymorphonuclear leukocyte plasma membranes with optical tweezers causes influx of extracellular calcium through membrane channels.
###end article-title 79
###begin article-title 80
###xml 82 88 <span type="species:ncbi:9986">rabbit</span>
Interactions of intracellular pH and intracellular calcium in primary cultures of rabbit corneal epithelial cells.
###end article-title 80
###begin article-title 81
TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway.
###end article-title 81
###begin p 82
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 82
###begin p 83
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MOST) (R01-2007-000-20263-0), Seoul R&BD Program (10541), and the NCRC program of MOST/KOSEF (R15-2006-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 83

